5 Best Performing Healthcare Stocks So Far in 2026

In this article, we will list the 5 Best Performing Healthcare Stocks So Far in 2026. Please visit 10 Best Performing Healthcare Stocks So Far in 2026 if you would like to see the extended list and the methodology behind it.

A healthcare professional in full protective gear performing a medical procedure.

5. Oruka Therapeutics, Inc. (NASDAQ:ORKA)

YTD Share Price Gain: 143.9%

Oruka Therapeutics, Inc. (NASDAQ:ORKA) is one of the best performing healthcare stocks so far in 2026. Leerink lifted the price target on Oruka Therapeutics, Inc. (NASDAQ:ORKA) to $120 from $109 on April 30, reaffirming an Outperform rating on the shares. In a separate development, Oruka Therapeutics, Inc. (NASDAQ:ORKA) announced on April 27 positive interim results from its EVERLAST-A Phase 2a trial of ORKA-001 in moderate-to-severe plaque psoriasis. ORKA-001 is a novel half-life extended IL-23p19 monoclonal antibody.

The company reported that ORKA-001 attained 63.5% (40/63) PASI 100 at Week 16, with a favorable safety profile consistent with the IL-23p19 class. It also stated that the updated Phase 1 PK/PD data continues to support the potential for once-yearly dosing, with longer-term EVERLAST-A data anticipated in H2 2026.

Dr. Bruce Strober, MD, PhD, Clinical Professor of Dermatology at Yale University School of Medicine and lead investigator for EVERLAST-A, stated that the data with ORKA-001 are “highly compelling”, adding that if “this type of efficacy and safety profile could be available with dosing once to twice per year, it would represent a major step forward for the field”.

Oruka Therapeutics, Inc. (NASDAQ:ORKA) is a biotechnology company that focuses on the development of novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002.